Finance

Lists
IKT:NASDAQ
Inhibikase Therapeutics Inc
$ 1.52
-0.65%
(-0.0100) 1D
11-р сарын 13, 16:00:01 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
$ 1.56
High
$ 1.58
Low
$ 1.48
Mkt. cap
213.21 сая
Avg. vol.
640.18 мян
Volume
333.13 мян
52-wk high
$ 2.61
52-wk low
$ 1.40
EPS
-$ 0.44
Beta
0.94
Shares outstanding
140.27 сая
No. of employees
35
Open
$ 1.56
High
$ 1.58
Low
$ 1.48
Mkt. cap
213.21 сая
Avg. vol.
640.18 мян
Volume
333.13 мян
52-wk high
$ 2.61
52-wk low
$ 1.40
EPS
-$ 0.44
Beta
0.94
Shares outstanding
140.27 сая
No. of employees
35
News stories
From web sources and news partners
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Делавар, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Websiteinhibikase.com
Analyst ratings
Based on 5 analysts giving stock ratings to IKT in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IKT in the last 3 months.
Highest
Current $ 1.52
$ 8.00 (+426.32%)
Average
$ 5.50 (+261.84%)
Lowest
$ 1.50 (-1.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 8.00
+426.3%
11/13/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$ 8.00
+426.3%
11/11/2026
Mazahir Alimohamed
Oppenheimer
Buy
Maintained
$ 5.00
+228.9%
11/11/2026
Andreas Argyrides
Chardan Capital
Hold
Initiated
$ 1.50
-1.3%
10/13/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$ 5.00
+228.9%
09/15/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
$ 6.00
+294.7%
07/27/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
$ 4.00
+163.2%
05/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$ 4.00
+163.2%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
-
-
-
-
Cost of goods sold
-21.63 сая
-
-
-
Cost of revenue
-21.63 сая
-
-
-
Research and development expenses
22.39 сая
10.84 сая
13.39 сая
15.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.77 сая
7.38 сая
7.66 сая
7.23 сая
Operating expense
29.17 сая
18.22 сая
21.05 сая
22.23 сая
Total operating expenses
7.53 сая
18.22 сая
21.05 сая
22.23 сая
Operating income
-7.53 сая
-18.22 сая
-21.05 сая
-22.23 сая
Other non operating income
-
1.46 сая
1.46 сая
1.76 сая
EBT including unusual items
-12.73 сая
-16.38 сая
-19.59 сая
-20.47 сая
EBT excluding unusual items
-6.49 сая
-16.75 сая
-19.59 сая
-20.47 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.73 сая
-16.38 сая
-19.59 сая
-20.47 сая
Net profit margin
-
-
-
-
Earnings per share
-
-0.10
-0.11
-0.11
Interest and investment income
1.04 сая
-
-
-
Interest expense
-
-
-
-
Net interest expenses
1.04 сая
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.53 сая
-18.20 сая
-21.04 сая
-22.21 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс